|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 676.69 USD | -0.33% |
|
+1.83% | -12.33% |
| 07-16 | Merck gets US FDA nod for first-in-its-class oral cholesterol drug | RE |
| 07-15 | Alnylam Initiates Mid-Stage Study of Mivelsiran in Down Syndrome-Associated Alzheimer's | MT |
EPS & Dividend: Regeneron Pharmaceuticals, Inc.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | 3.52 | 3.903 | 4.433 | 5.045 |
| Rate of return | - | - | - | - | 0.46% | 0.58% | 0.66% | 0.75% |
| EPS 2 | 71.97 | 38.22 | 34.77 | 38.34 | 41.48 | 38.09 | 47.47 | 54.87 |
| Distribution rate | - | - | - | - | 8.49% | 10.2% | 9.34% | 9.2% |
| Reference price 2 | 631.52 | 721.49 | 878.29 | 712.33 | 771.87 | 676.69 | 676.69 | 676.69 |
| Nbr of stocks (in thousands) | 104,556 | 106,802 | 106,347 | 107,590 | 102,599 | 101,739 | - | - |
| Announcement Date | 04/02/22 | 03/02/23 | 02/02/24 | 04/02/25 | 30/01/26 | - | - | - |
Past dividends: Regeneron Pharmaceuticals, Inc.
| 20/05/2026 | Ex-dividend date - 0.94 USD | 08:00 |
| 20/02/2026 | Ex-dividend date - 0.94 USD | 09:00 |
| 20/11/2025 | Ex-dividend date - 0.88 USD | 09:00 |
| 18/08/2025 | Ex-dividend date - 0.88 USD | 08:00 |
Upcoming Events: Regeneron Pharmaceuticals, Inc.
| 30/07/2026 | Earnings release | Q2 2026 | |
| 30/07/2026 | Earnings presentation | 16:30 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.58% | 0.66% | 17.76x | 2.02x | 3.85x | |
| 0.61% | 0.63% | 25.64x | 3.88x | 5.3x | |
| -.--% | -.--% | 34.55x | 6.94x | 11.7x | |
| 3.31% | 3.4% | -46.16x | 2.53x | 3.26x | |
| -.--% | -.--% | 24.47x | 1.63x | 3.57x | |
| -.--% | -.--% | -7.13x | 4.33x | 10.08x | |
| -.--% | -.--% | 41.9x | - | - | |
| -.--% | 0.05% | 64.32x | 5.78x | 6.31x | |
| -.--% | -.--% | 24.47x | 3.59x | 5.19x | |
| -.--% | -.--% | -36.62x | -6.49x | 17.52x | |
| Average | 0.45% | 0.47% | 14.32x | 2.69x | 7.42x | |
| Weighted average by Cap. | 0.62% | 0.65% | 14.27x | 3.11x | 6.49x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition